Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
View: Text | PDF
Research Article Endocrinology Metabolism

14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells

  • Text
  • PDF
Abstract

While critical for neurotransmitter synthesis, 14-3-3 proteins are often assumed to have redundant functions due to their ubiquitous expression, but despite this assumption, various 14-3-3 isoforms have been implicated in regulating metabolism. We previously reported contributions of 14-3-3ζ in β cell function, but these studies were performed in tumor-derived MIN6 cells and systemic KO mice. To further characterize the regulatory roles of 14-3-3ζ in β cell function, we generated β cell–specific 14-3-3ζ–KO mice. Although no effects on β cell mass were detected, potentiated glucose-stimulated insulin secretion (GSIS), mitochondrial function, and ATP synthesis were observed. Deletion of 14-3-3ζ also altered the β cell transcriptome, as genes associated with mitochondrial respiration and oxidative phosphorylation were upregulated. Acute 14-3-3 protein inhibition in mouse and human islets recapitulated the enhancements in GSIS and mitochondrial function, suggesting that 14-3-3ζ is the critical isoform in β cells. In dysfunctional db/db islets and human islets from type 2 diabetic donors, expression of Ywhaz/YWHAZ, the gene encoding 14-3-3ζ, was inversely associated with insulin secretion, and pan–14-3-3 protein inhibition led to enhanced GSIS and mitochondrial function. Taken together, this study demonstrates important regulatory functions of 14-3-3ζ in the regulation of β cell function and provides a deeper understanding of how insulin secretion is controlled in β cells.

Authors

Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim

×

Figure 2

Pharmacological inhibition of 14-3-3 proteins in human pancreatic islets enhances insulin secretion, mitochondrial function, and proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Pharmacological inhibition of 14-3-3 proteins in human pancreatic islets...
(A) Human islets were incubated with 2 pan–14-3-3 inhibitors (14-3-3i and BVO2; 10 μM each) plus or minus diazoxide (DZ, 200μM) for 1 hour at 4 mM glucose prior to treatment with 4 (4G) or 16 (16G) mM glucose for 1 hour. Insulin secretion was measured by radioimmunoassay and normalized to total insulin content (n = 5–6 donors per group; #P < 0.05 when compared with DMSO 4 G; *P < 0.05, ***P < 0.001 when compared with DMSO 16G). (B) Quantification of total insulin content (TIC) in acid-ethanol extracts from each (n = 5–6 donors per group). (C) Combined OCR trace, with basal OCRs in the inset image, showing when islets were treated with (line A) 16 mM glucose, (line B) oligomycin (5 μM), (line C) FCCP (1 μM), and (line D) rotenone (5 μM) and antimycin (5 μM). (D and E) OCR in response to glucose (D) and ATP-linked oxygen consumption (E) were measured. ATP-linked OCR was calculated by measuring the decrease in OCR upon injection of oligomycin. (n = 5–6 donors per group; *P < 0.05 when compared with DMSO). (F) Biochemical measurements of ATP content in isolated mouse islets treated with 14-3-3 inhibitors and quantified at different glucose concentrations (n = 7 donors per group; *P < 0.05). (G) In dispersed mouse islet preparations, β cell proliferation, as measured by immunofluorescent staining for Insulin+ and Ki-67+ β cells, was measured after 72-hour treatment with DMSO, 14-3-3 inhibitors (10 μM each), or harmine (10 μM) (n = 3 donors per group; *P < 0.05). Significance was determined by 1-way ANOVA, followed by Dunnett’s test (C–E and G), or by 2-way ANOVA, followed by Tukey’s multiple-comparison test (A and F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts